BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zumla A, Hui DSC. Emerging and Reemerging Infectious Diseases: Global Overview. Infect Dis Clin North Am 2019;33:xiii-xix. [PMID: 31668202 DOI: 10.1016/j.idc.2019.09.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Murugan NA, Raja KMP, Saraswathi NT. Peptide-Based Antiviral Drugs. Adv Exp Med Biol 2021;1322:261-84. [PMID: 34258744 DOI: 10.1007/978-981-16-0267-2_10] [Reference Citation Analysis]
2 Wang WH, Thitithanyanont A, Urbina AN, Wang SF. Emerging and Re-Emerging Diseases. Pathogens 2021;10:827. [PMID: 34209374 DOI: 10.3390/pathogens10070827] [Reference Citation Analysis]
3 Dlangalala T, Musekiwa A, Brits A, Maluleke K, Jaya ZN, Kgarosi K, Mashamba-Thompson T. Evidence of TB Services at Primary Healthcare Level during COVID-19: A Scoping Review. Diagnostics (Basel) 2021;11:2221. [PMID: 34943458 DOI: 10.3390/diagnostics11122221] [Reference Citation Analysis]
4 Devnath P, Masud HMAA. Nipah virus: a potential pandemic agent in the context of the current severe acute respiratory syndrome coronavirus 2 pandemic. New Microbes New Infect 2021;41:100873. [PMID: 33758670 DOI: 10.1016/j.nmni.2021.100873] [Reference Citation Analysis]
5 Sukmarini L. Antiviral Peptides (AVPs) of Marine Origin as Propitious Therapeutic Drug Candidates for the Treatment of Human Viruses. Molecules 2022;27:2619. [PMID: 35565968 DOI: 10.3390/molecules27092619] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Sayeed MA, Paisie T, Alam MT, Ali A, Camilli A, Wrammert J, Khan AI, Qadri F, Salemi M, Morris JG, Nelson EJ. Development of a Monoclonal Antibody to a Vibriophage as a Proxy for Vibrio cholerae Detection. Infect Immun 2022;:e0016122. [PMID: 35862704 DOI: 10.1128/iai.00161-22] [Reference Citation Analysis]
7 Zumla A, Niederman MS. Editorial: The explosive epidemic outbreak of novel coronavirus disease 2019 (COVID-19) and the persistent threat of respiratory tract infectious diseases to global health security. Curr Opin Pulm Med 2020;26:193-6. [PMID: 32132379 DOI: 10.1097/MCP.0000000000000676] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
8 Rugarabamu S, Rumisha SF, Mwanyika GO, Sindato C, Lim H, Misinzo G, Mboera LEG. Viral haemorrhagic fevers and malaria co-infections among febrile patients seeking health care in Tanzania. Infect Dis Poverty 2022;11. [DOI: 10.1186/s40249-022-00959-z] [Reference Citation Analysis]
9 Pourseif MM, Parvizpour S, Jafari B, Dehghani J, Naghili B, Omidi Y. A domain-based vaccine construct against SARS-CoV-2, the causative agent of COVID-19 pandemic: development of self-amplifying mRNA and peptide vaccines. Bioimpacts 2021;11:65-84. [PMID: 33469510 DOI: 10.34172/bi.2021.11] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
10 Cai L, Xu L, Si Y, Yu J, Ding B. Autoclavable, Breathable, and Waterproof Membranes Tailored by Ternary Nanofibers for Reusable Medical Protective Applications. ACS Appl Polym Mater 2022;4:556-64. [DOI: 10.1021/acsapm.1c01460] [Reference Citation Analysis]
11 Oliveira DVB, da Silva JF, de Sousa Araújo TA, Albuquerque UP. Influence of Religiosity and Spirituality on the Adoption of Behaviors of Epidemiological Relevance in Emerging and Re-Emerging Diseases: The Case of Dengue Fever. J Relig Health 2021. [PMID: 34581946 DOI: 10.1007/s10943-021-01436-x] [Reference Citation Analysis]
12 Davis MDM. ‘Live with the Virus’ Narrative and Pandemic Amnesia in the Governance of COVID-19. Social Sciences 2022;11:340. [DOI: 10.3390/socsci11080340] [Reference Citation Analysis]
13 Ippolito G, Lauria FN, Locatelli F, Magrini N, Montaldo C, Sadun R, Maeurer M, Strada G, Vairo F, Curiale S, Lafont A, di Caro A, Capobianchi MR, Meilicke R, Petersen E, Zumla A, Pletschette M. Lessons from the COVID-19 Pandemic-Unique Opportunities for Unifying, Revamping and Reshaping Epidemic Preparedness of Europe's Public Health Systems. Int J Infect Dis 2020;101:361-6. [PMID: 33152511 DOI: 10.1016/j.ijid.2020.10.094] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zhang D, Yang Y, Li M, Lu Y, Liu Y, Jiang J, Liu R, Liu J, Huang X, Li G, Qu J. Ecological Barrier Deterioration Driven by Human Activities Poses Fatal Threats to Public Health due to Emerging Infectious Diseases. Engineering (Beijing) 2021. [PMID: 33903827 DOI: 10.1016/j.eng.2020.11.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
15 Zhao Z, Feng M, Wan J, Zheng X, Teng C, Xie X, Pan W, Hu B, Huang J, Liu Z, Wu J, Cai S. Research progress of epigallocatechin-3-gallate (EGCG) on anti-pathogenic microbes and immune regulation activities. Food Funct 2021;12:9607-19. [PMID: 34549212 DOI: 10.1039/d1fo01352a] [Reference Citation Analysis]